B68607

Sigma-Aldrich

5-Bromoindole

99%

Empirical Formula (Hill Notation):
C8H6BrN
CAS Number:
Molecular Weight:
196.04
Beilstein/REAXYS Number:
112877
EC Number:
MDL number:
PubChem Substance ID:
NACRES:
NA.22

Quality Level

assay

99%

mp

90-92 °C (lit.)

SMILES string

Brc1ccc2[nH]ccc2c1

InChI

1S/C8H6BrN/c9-7-1-2-8-6(5-7)3-4-10-8/h1-5,10H

InChI key

VXWVFZFZYXOBTA-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

RIDADR

NONH for all modes of transport

WGK Germany

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Hui Peng et al.
Environmental science & technology, 50(1), 321-330 (2015-12-01)
Previously unreported natural and synthetic organo-bromine compounds (NSOBCs) have been found to contribute more than 99% of total organic bromine (TOB) in environmental matrices. We recently developed a novel untargeted method (data-independent precursor isolation and characteristic fragment, DIPIC-Frag) and identified...
Lisa Cooper et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 24(23), 6105-6114 (2018-02-03)
Optimisation, scope and mechanism of the platinum-catalysed addition of indoles to indolylallenes is reported here to give 2,3'-BIMs with a novel core structure very relevant for pharmaceutical industry. The reaction is modulated by the electronic properties of the substituents on...
Minna K Rahnasto et al.
Bioorganic & medicinal chemistry, 19(23), 7186-7193 (2011-10-25)
The human CYP2A6 enzyme metabolises several xenobiotics including nicotine, the addictive component in tobacco. Reduced activity of CYP2A6, either for genetic reasons or by administering inhibitors of CYP2A6, reduces tobacco smoking. The aim was to design novel inhibitors of CYP2A6...
Niina Tani et al.
Bioorganic & medicinal chemistry, 22(23), 6655-6664 (2014-12-03)
Inhibition of CYP2A6-mediated nicotine metabolism can reduce cigarette smoking. We sought potent and selective CYP2A6 inhibitors to be used as leads for drugs useful in smoking reduction therapy, by evaluating CYP2A6 inhibitory effect of novel formyl, alkyl amine or carbonitrile...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.